CPSC official recall · 23154

Pfizer Recalls Nurtec ODT Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning

召回日期：2023-03-16官方最后发布：2023-03-16适用地区：美国

重要：以下安全事实保留 CPSC 官方英文原文，避免翻译改变含义。请通过右侧官方公告确认行动要求。

危险说明 Hazard

The recalled prescription drugs must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

受影响产品

Nurtec® ODT (rimegepant) orally disintegrating tablets, 75mg 8-Unit Dose blister pack

Units：About 4.2 million

官方描述 Description

This recall involves prescription drugs Nurtec ODT 75 mg orally disintegrating tablets sold in cartons containing one blister card of 8 tablets. The tablets are in a non-child resistant blister card packaged in a carton that includes the name of the product, dosage strength, expiration date. The dosage strength and expiration date are printed or stamped on the blister card. The recall includes the following: Product Description NDC Number Expiration Date Nurtec® ODT (rimegepant) 75mg 8-Unit Dose blister pack 72618-3000-2 All dates through 6/2026

事故与伤害 Incidents / Injuries

None reported

官方补救措施 Remedy

Consumers should immediately secure the recalled product out of the sight and reach of children and contact Pfizer for a free child resistant pouch to store the product. Once the product is secured, consumers can continue to use it as directed.

Options：New Instructions · Repair

消费者联系信息

Pfizer at 800-879-3477 Monday through Friday 9 a.m. to 7 p.m. ET, online at www.pfizer.com/contact or online at www.Nurtec.com/PackagingUpdate or www.Nurtec.com and click "Recall to provide child resistant pouches to patients for storage of their medicine. Click for details" for more information.